Neuberger Berman Group LLC Bio N Tech Se Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q2 2024
A detailed history of Neuberger Berman Group LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Neuberger Berman Group LLC holds 14,872 shares of BNTX stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,872
Previous 15,312
2.87%
Holding current value
$1.77 Million
Previous $1.41 Million
15.37%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$983 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$569 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$520 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$348 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$225 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...